Seeking Alpha

The Shareholders Foundation announces an investigation on behalf of Celgene (CELG +2.1%)...

The Shareholders Foundation announces an investigation on behalf of Celgene (CELG +2.1%) shareholders over whether the company made "potentially materially false and misleading" statements about its prospects and operations. The announcement cites the long run-up in Celgene's shares before they plunged following a regulatory setback for its Revlimid drug.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|